SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-18-157563
Filing Date
2018-05-09
Accepted
2018-05-09 16:20:56
Documents
65
Period of Report
2018-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d562464d10q.htm 10-Q 348728
2 EX-10.1 d562464dex101.htm EX-10.1 12818
3 EX-31.1 d562464dex311.htm EX-31.1 6303
4 EX-31.2 d562464dex312.htm EX-31.2 6375
5 EX-32.1 d562464dex321.htm EX-32.1 4426
6 EX-32.2 d562464dex322.htm EX-32.2 4323
  Complete submission text file 0001193125-18-157563.txt   3135089

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT ccxi-20180331.xml EX-101.INS 554515
8 XBRL TAXONOMY EXTENSION SCHEMA ccxi-20180331.xsd EX-101.SCH 43635
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ccxi-20180331_cal.xml EX-101.CAL 55862
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ccxi-20180331_def.xml EX-101.DEF 142237
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE ccxi-20180331_lab.xml EX-101.LAB 344239
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ccxi-20180331_pre.xml EX-101.PRE 258093
Mailing Address 850 MAUDE AVENUE MOUNTAIN VIEW CA 94043
Business Address 850 MAUDE AVENUE MOUNTAIN VIEW CA 94043 650-210-2900
ChemoCentryx, Inc. (Filer) CIK: 0001340652 (see all company filings)

IRS No.: 943254365 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35420 | Film No.: 18818571
SIC: 2834 Pharmaceutical Preparations